These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 38022292)

  • 1. The Effectiveness of Polypill for the Prevention of Cardiovascular Disease: A Meta-Analysis of Randomized Controlled Trials.
    Virk GS; Sharma A; Khan MR; Shah K; Mengar J; Chaudhari SS; Batool S; Saleem F
    Cureus; 2023 Oct; 15(10):e47032. PubMed ID: 38022292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of polypill therapy with cardiovascular outcomes, mortality, and adherence: A systematic review and meta-analysis of randomized controlled trials.
    Rao S; Jamal Siddiqi T; Khan MS; Michos ED; Navar AM; Wang TJ; Greene SJ; Prabhakaran D; Khera A; Pandey A
    Prog Cardiovasc Dis; 2022; 73():48-55. PubMed ID: 35114251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polypill for cardiovascular disease prevention: Systematic review and meta-analysis of randomized controlled trials.
    Mohamed MG; Osman M; Kheiri B; Saleem M; Lacasse A; Alkhouli M
    Int J Cardiol; 2022 Aug; 360():91-98. PubMed ID: 35641323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
    Palmer MJ; Barnard S; Perel P; Free C
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012675. PubMed ID: 29932455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fixed-dose combination therapy for the prevention of cardiovascular disease.
    de Cates AN; Farr MR; Wright N; Jarvis MC; Rees K; Ebrahim S; Huffman MD
    Cochrane Database Syst Rev; 2014 Apr; 4(4):CD009868. PubMed ID: 24737108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
    Palmer MJ; Machiyama K; Woodd S; Gubijev A; Barnard S; Russell S; Perel P; Free C
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012675. PubMed ID: 33769555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polypill-based strategy vs. usual care for secondary prevention of cardiovascular disease: a meta-analysis of randomized controlled trials.
    Rivera A; Campos B; Ceolin S; Godoi A; Castanha E; Campello Jorge CA; Cardoso R
    Eur J Prev Cardiol; 2023 Nov; 30(16):1828-1837. PubMed ID: 37490769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the Polypill on Adherence and Prevention of Cardiovascular Diseases in Patients With or at High Risk of Cardiovascular Diseases: A Meta-Analysis of Randomized Controlled Trials.
    Memon RA; Raveena Bai B; Simran F; Kumari M; Aisha F; Sai Kiran K; Kakarlapudi Y; Saleem F
    Cureus; 2023 Jan; 15(1):e34134. PubMed ID: 36843692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tai chi for primary prevention of cardiovascular disease.
    Hartley L; Flowers N; Lee MS; Ernst E; Rees K
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010366. PubMed ID: 24715694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication Adherence With Polypill in Cardiovascular Disease and High-Risk Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Involving 7364 Participants.
    Sadeghi M; Askari A; Bostan F; Heidari A; Ghasemi G; Alavi Tabatabaei G; Rafiee H; Karimi R; Roohafza H
    Curr Probl Cardiol; 2024 Jan; 49(1 Pt A):102061. PubMed ID: 37640178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple risk factor interventions for primary prevention of cardiovascular disease in low- and middle-income countries.
    Uthman OA; Hartley L; Rees K; Taylor F; Ebrahim S; Clarke A
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011163. PubMed ID: 26272648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polypill Therapy in Cardiovascular Disease: A Meta-Analysis of Randomized Controlled Trials.
    Hennawi HA; Ashraf MT; Zohaib M; Khan MK; Khan IA; Muhammadzai HZU; Memon RA; Sadiq U; Siddiqi A; Roomi S; Nair A
    Curr Probl Cardiol; 2023 Aug; 48(8):101735. PubMed ID: 37044270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease.
    Flowers N; Hartley L; Todkill D; Stranges S; Rees K
    Cochrane Database Syst Rev; 2014; 2014(12):CD010405. PubMed ID: 25474484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of fixed dose combination medication ('polypills') compared with usual care in patients with cardiovascular disease or at high risk: A prospective, individual patient data meta-analysis of 3140 patients in six countries.
    Webster R; Patel A; Selak V; Billot L; Bots ML; Brown A; Bullen C; Cass A; Crengle S; Raina Elley C; Grobbee DE; Neal B; Peiris D; Poulter N; Prabhakaran D; Rafter N; Stanton A; Stepien S; Thom S; Usherwood T; Wadham A; Rodgers A;
    Int J Cardiol; 2016 Feb; 205():147-156. PubMed ID: 26736090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of a fixed dose combination (polypill) in secondary prevention of cardiovascular diseases in India: Within-trial cost-effectiveness analysis of the UMPIRE trial.
    Singh K; Crossan C; Laba TL; Roy A; Hayes A; Salam A; Jan S; Lord J; Tandon N; Rodgers A; Patel A; Thom S; Prabhakaran D
    Int J Cardiol; 2018 Jul; 262():71-78. PubMed ID: 29622506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits of the Polypill on Medication Adherence in the Primary and Secondary Prevention of Cardiovascular Disease: A Systematic Review.
    Lopez-Lopez JP; Gonzalez AM; Lanza P; Lopez-Jaramillo P
    Vasc Health Risk Manag; 2023; 19():605-615. PubMed ID: 37719697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimated cardiovascular relative risk reduction from fixed-dose combination pill (polypill) treatment in a wide range of patients with a moderate risk of cardiovascular disease.
    Lafeber M; Webster R; Visseren FLj; Bots ML; Grobbee DE; Spiering W; Rodgers A;
    Eur J Prev Cardiol; 2016 Aug; 23(12):1289-97. PubMed ID: 26743587
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.